文献速递心脑血管急症重症综合管理与镇静镇痛

住院老年患者强化住院血压管理的临床结局

Clinical Outcomes of Intensive Inpatient Blood Pressure Management in Hospitalized Older Adults.
PubMed 文献 · JAMA Intern Med · 2023-01-01
一句话结论住院老年患者非心脏疾病住院期间强化降压与不良结局风险升高相关,不支持下述治疗:无终末器官损害证据的住院血压升高(作者结论)。

这项回顾性队列研究利用2015年10月1日至2017年12月31日退伍军人健康管理局数据,纳入66140例因非心血管诊断住院且入院48小时内血压升高的65岁及以上患者,其中14084例(21.3%)在入院48小时内接受强化降压治疗(静脉降压药或入院前未使用的口服降压药类别)。采用倾向评分重叠加权调整混杂后,强化治疗与主要复合终点风险升高相关(1220例[8.7%] vs 3570例[6.9%];加权OR 1.28;95%CI 1.18-1.39),静脉降压药亚组风险最高(加权OR 1.90;95%CI 1.65-2.19)。除卒中和死亡外,强化治疗患者更可能发生复合终点的各组成部分,各亚组结果一致。作者结论认为,这些发现不支持对无终末器官损害证据的住院血压升高进行治疗,并强调需要开展住院血压治疗目标的随机临床试验。

要点

  • 在66140例住院老年患者中,21.3%在入院48小时内接受强化降压,主要复合终点发生率8.7% vs 6.9%(加权OR 1.28;95%CI 1.18-1.39)。
  • 接受静脉降压药者主要复合终点风险最高(加权OR 1.90;95%CI 1.65-2.19)。
  • 强化治疗患者除卒中和死亡外,更可能发生复合终点的各组成部分。
  • 按年龄、衰弱、入院前血压、早期住院血压和心血管病史分层的各亚组结果一致。
  • 作者结论:这些发现不支持对无终末器官损害证据的住院血压升高进行治疗,并强调需要住院血压治疗目标的随机临床试验。

适用人群与场景

  • 年龄65岁及以上、因非心血管诊断住院、且在住院最初48小时内出现血压升高的退伍军人健康管理局患者(2015年10月1日至2017年12月31日)。

处置流程与药物剂量

  • 强化降压治疗定义为住院最初48小时后接受静脉降压药或入院前未使用的口服降压药类别。

研究设计与关键结果

  • 研究类型:回顾性队列研究;样本量66140例;人群平均(SD)年龄74.4(8.1)岁;97.5%男性、2.6%女性;17.4%黑人、1.7%西班牙裔、75.9%白人。
  • 14084例(21.3%)在住院最初48小时内接受强化降压治疗;强化治疗组后续住院期间继续接受更多额外降压药(平均额外剂量6.1[95%CI 5.8-6.4] vs 1.6[95%CI 1.5-1.8])。
  • 主要复合终点(住院死亡、ICU转入、卒中、急性肾损伤、B型利钠肽升高和肌钙蛋白升高):强化治疗组1220例(8.7%) vs 未强化治疗组3570例(6.9%);加权OR 1.28;95%CI 1.18-1.39。
  • 静脉降压药亚组主要复合终点风险最高:加权OR 1.90;95%CI 1.65-2.19。
  • 强化治疗患者更可能发生复合终点的各组成部分,但卒中和死亡除外。
  • 按年龄、衰弱、入院前血压、早期住院血压和心血管病史分层的各亚组结果一致。

证据类型、等级与局限

  • 证据类型:回顾性队列研究;原文未报告证据等级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,这些发现不支持对无终末器官损害证据的住院血压升高进行治疗;并强调需要开展住院血压治疗目标的随机临床试验。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Asymptomatic blood pressure (BP) elevations are common in hospitalized older adults, and widespread heterogeneity in the clinical management of elevated inpatient BPs exists.

OBJECTIVE: To examine the association of intensive treatment of elevated inpatient BPs with in-hospital clinical outcomes of older adults hospitalized for noncardiac conditions.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study examined Veterans Health Administration data between October 1, 2015, and December 31, 2017, for patients aged 65 years or older hospitalized for noncardiovascular diagnoses and who experienced elevated BPs in the first 48 hours of hospitalization.

INTERVENTIONS: Intensive BP treatment following the first 48 hours of hospitalization, defined as receipt of intravenous antihypertensives or oral classes not used prior to admission.

MAIN OUTCOME AND MEASURES: The primary outcome was a composite of inpatient mortality, intensive care unit transfer, stroke, acute kidney injury, B-type natriuretic peptide elevation, and troponin elevation. Data were analyzed between October 1, 2021, and January 10, 2023, with propensity score overlap weighting used to adjust for confounding between those who did and did not receive early intensive treatment.

RESULTS: Among 66 140 included patients (mean [SD] age, 74.4 [8.1] years; 97.5% male and 2.6% female; 17.4% Black, 1.7% Hispanic, and 75.9% White), 14 084 (21.3%) received intensive BP treatment in the first 48 hours of hospitalization. Patients who received early intensive treatment vs those who did not continued to receive a greater number of additional antihypertensives during the remainder of their hospitalization (mean additional doses, 6.1 [95% CI, 5.8-6.4] vs 1.6 [95% CI, 1.5-1.8], respectively). Intensive treatment was associated with a greater risk of the primary composite outcome (1220 [8.7%] vs 3570 [6.9%]; weighted odds ratio [OR], 1.28; 95% CI, 1.18-1.39), with the highest risk among patients receiving intravenous antihypertensives (weighted OR, 1.90; 95% CI, 1.65-2.19). Intensively treated patients were more likely to experience each component of the composite outcome except for stroke and mortality. Findings were consistent across subgroups stratified by age, frailty, preadmission BP, early hospitalization BP, and cardiovascular disease history.

CONCLUSIONS AND RELEVANCE: The study's findings indicate that among hospitalized older adults with elevated BPs, intensive pharmacologic antihypertensive treatment was associated with a greater risk of adverse events. These findings do not support the treatment of elevated inpatient BPs without evidence of end organ damage, and they highlight the need for randomized clinical trials of inpatient BP treatment targets.

来源:JAMA Intern Med,查看原文。版权归原作者所有。

参考来源

  1. Anderson TS, Herzig SJ, Jing B, et al. Clinical Outcomes of Intensive Inpatient Blood Pressure Management in Hospitalized Older Adults. JAMA Intern Med. 2023. PMID: 37252732. doi:10.1001/jamainternmed.2023.1667

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。